HighTower Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $387K | Buy |
141,152
+27,253
| +24% | +$86.3K | ﹤0.01% | 2943 |
|
|
2025
Q4 | $421K | Sell |
113,899
-6,112
| -5% | -$19.8K | ﹤0.01% | 2763 |
|
|
2025
Q3 | $318K | Buy |
120,011
+1,672
| +1% | +$3.23K | ﹤0.01% | 2997 |
|
|
2025
Q2 | $116K | Sell |
118,339
-6,547
| -5% | -$6.56K | ﹤0.01% | 3438 |
|
|
2025
Q1 | $180K | Buy |
124,886
+20,625
| +20% | +$38K | ﹤0.01% | 3224 |
|
|
2024
Q4 | $229K | Sell |
104,261
-1,310
| -1% | -$3.06K | ﹤0.01% | 3098 |
|
|
2024
Q3 | $176K | Sell |
105,571
-131,214
| -55% | -$265K | ﹤0.01% | 3179 |
|
|
2024
Q2 | $514K | Buy |
236,785
+49,619
| +27% | +$117K | ﹤0.01% | 2298 |
|
|
2024
Q1 | $496K | Buy |
187,166
+137,597
| +278% | +$334K | ﹤0.01% | 2293 |
|
|
2023
Q4 | $149K | Buy |
49,569
+25,211
| +104% | +$32.7K | ﹤0.01% | 3094 |
|
|
2023
Q3 | $23K | Buy |
24,358
+765
| +3% | +$1.11K | ﹤0.01% | 3314 |
|
|
2023
Q2 | $32K | Buy |
+23,593
| New | +$32.9K | ﹤0.01% | 3211 |
|
|
2020
Q4 | – | Sell |
-32,753
| Closed | -$1.22M | – | 2684 |
|
|
2020
Q3 | $1.22M | Buy |
32,753
+12,185
| +59% | +$483K | 0.01% | 1114 |
|
|
2020
Q2 | $1.06M | Sell |
20,568
-25
| -0.1% | -$1.05K | 0.01% | 1091 |
|
|
2020
Q1 | $650K | Sell |
20,593
-1,275
| -6% | -$67.3K | ﹤0.01% | 1211 |
|
|
2019
Q4 | $1.3M | Buy |
21,868
+1,519
| +7% | +$68.3K | 0.01% | 1019 |
|
|
2019
Q3 | $744K | Sell |
20,349
-7,766
| -28% | -$308K | ﹤0.01% | 1330 |
|
|
2019
Q2 | $1.3M | Buy |
28,115
+8,926
| +47% | +$419K | 0.01% | 1068 |
|
|
2019
Q1 | $770K | Buy |
19,189
+1,228
| +7% | +$55.1K | 0.01% | 1252 |
|
|
2018
Q4 | $825K | Buy |
17,961
+411
| +2% | +$19.8K | 0.01% | 1123 |
|
|
2018
Q3 | $778K | Buy |
+17,550
| New | +$806K | 0.01% | 1245 |
|
Other funds holding ESPR
WA
TSC
O
VCM
